Search Ontology:
ChEBI
sitagliptin
- Term ID
- CHEBI:40237
- Synonyms
-
- (2R)-4-OXO-4-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE
- (3R)-3-amino-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)butan-1-one
- MK-0431
- sitagliptin
- sitagliptina
- sitagliptine
- sitagliptinum
- Definition
- A triazolopyrazine that exhibits hypoglycemic activity.
- References
-
- Beilstein:9962060
- CAS:486460-32-6
- DrugBank:DB01261
- Drug_Central:2448
- HMDB:HMDB0015390
- KEGG:D08516
- LINCS:LSM-5363
- PDBeChem:715
- PMID:23286208
- PMID:23331339
- PMID:23432786
- PMID:23489256
- PMID:23927568
- PMID:24039399
- PMID:24041927
- Reaxys:9962060
- Wikipedia:Sitagliptin
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
- inverse has_functional_parent
-
Phenotype
Phenotype resulting from sitagliptin
Phenotype where environments contain sitagliptin
Phenotype modified by environments containing sitagliptin
Human Disease Model